International Trends in the Incidence of Testicular Cancer: Lessons from 35 Years and 41 Countries
- PMID: 31324498
- PMCID: PMC8653517
- DOI: 10.1016/j.eururo.2019.07.002
International Trends in the Incidence of Testicular Cancer: Lessons from 35 Years and 41 Countries
Abstract
Background: Incidence rates of testicular cancer (TC) have been increasing in many countries since, at least, the mid-20th century without clear explanation. Examining the varying trends across countries and time provides clues to understanding the causes of TC.
Objective: We have presented incidence data from 41 countries and evaluated incidence trends for the 35-yr period from 1978 to 2012.
Design, setting, and participants: Cancer registry data from Cancer Incidence in Five Continents (CI5) volumes V-XI, CI5plus, and the NORDCAN database were analysed.
Outcome measurements and statistical analysis: Age-standardised rates of TC overall and by histological type were calculated. A joinpoint regression model of the natural log-transformed rates was used to calculate the average annual percent change (AAPC) in incidence. Age-period-cohort modelling was used to examine the effect of birth cohort on rates.
Results and limitations: While the highest incidence of TC remains in Northern Europe, the gap is closing between higher- and lower-incidence regions. Age-period-cohort modelling found flattening of risk among recent cohorts in Denmark and the UK, a steady increase in risk in the USA (particularly for seminomas), and an increase in risk among more recent cohorts in Costa Rica, Croatia, and Slovakia.
Conclusions: The gap between low- and high-incidence countries is closing due to increases in the former and stabilisation in the latter. Understanding the causes of these and other differences in incidence rates between, and within, countries may help further our understanding of the aetiology of this cancer.
Patient summary: We examined the rates of testicular cancer in different countries over time. These rates have been increasing, although the rates in high-incidence countries seem to be slowing down, while rates in low-incidence countries are catching up. These trends might help us understand what is causing testicular cancer in general.
Keywords: Global trends; Incidence; Testicular cancer; Testicular germ cell tumours.
Copyright © 2019 European Association of Urology. All rights reserved.
Figures
Comment in
-
Perspectives on a Global Change in Testicular Cancer Incidence.Eur Urol. 2019 Nov;76(5):624-625. doi: 10.1016/j.eururo.2019.07.038. Epub 2019 Aug 4. Eur Urol. 2019. PMID: 31387762 No abstract available.
-
Urological Oncology: Testis Cancer and Advances in Oncologic Therapy.J Urol. 2021 Oct;206(4):1065. doi: 10.1097/JU.0000000000002129. Epub 2021 Jul 20. J Urol. 2021. PMID: 34281350 No abstract available.
References
-
- Winter C, Albers P. Testicular germ cell tumors: Pathogenesis, diagnosis and treatment. Nature Reviews Endocrinology. 2011;7(1):43–53. - PubMed
-
- Brydøy M, Fosså SD, Klepp O, et al. Paternity following treatment for testicular cancer. Journal of the National Cancer Institute. 2005;97(21):1580–1588. - PubMed
-
- Pühse G, Wachsmuth JU, Kemper S, Husstedt IW, Evers S, Kliesch S. Chronic pain has a negative impact on sexuality in testis cancer survivors. Journal of Andrology. 2012;33(5):886–893. - PubMed
-
- Fosså SD. Long-term sequelae after cancer therapy: Survivorship after treatment for testicular cancer. Acta Oncologica. 2004;43(2):134–141. - PubMed
Publication types
MeSH terms
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
